These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 17462568)

  • 1. A direct inhibitor of HMGB1 cytokine.
    Girard JP
    Chem Biol; 2007 Apr; 14(4):345-7. PubMed ID: 17462568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycyrrhizic acid affords robust neuroprotection in the postischemic brain via anti-inflammatory effect by inhibiting HMGB1 phosphorylation and secretion.
    Kim SW; Jin Y; Shin JH; Kim ID; Lee HK; Park S; Han PL; Lee JK
    Neurobiol Dis; 2012 Apr; 46(1):147-56. PubMed ID: 22266336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycyrrhizin binds to high-mobility group box 1 protein and inhibits its cytokine activities.
    Mollica L; De Marchis F; Spitaleri A; Dallacosta C; Pennacchini D; Zamai M; Agresti A; Trisciuoglio L; Musco G; Bianchi ME
    Chem Biol; 2007 Apr; 14(4):431-41. PubMed ID: 17462578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HMGB1 as a mediator of necrosis-induced inflammation and a therapeutic target in arthritis.
    Andersson U; Tracey KJ
    Rheum Dis Clin North Am; 2004 Aug; 30(3):627-37, xi. PubMed ID: 15261345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High mobility group box chromosomal protein 1 as a nuclear protein, cytokine, and potential therapeutic target in arthritis.
    Ulloa L; Batliwalla FM; Andersson U; Gregersen PK; Tracey KJ
    Arthritis Rheum; 2003 Apr; 48(4):876-81. PubMed ID: 12687528
    [No Abstract]   [Full Text] [Related]  

  • 6. Glycyrrhizic acid confers neuroprotection after subarachnoid hemorrhage via inhibition of high mobility group box-1 protein: a hypothesis for novel therapy of subarachnoid hemorrhage.
    Sun Q; Wang F; Li W; Li W; Hu YC; Li S; Zhu JH; Zhou M; Hang CH
    Med Hypotheses; 2013 Oct; 81(4):681-5. PubMed ID: 23932051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment with HMGB1 inhibitors diminishes CTL-induced liver disease in HBV transgenic mice.
    Sitia G; Iannacone M; Müller S; Bianchi ME; Guidotti LG
    J Leukoc Biol; 2007 Jan; 81(1):100-7. PubMed ID: 16935945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of Glycyrrhizin, an inhibitor of HMGB1 protein, in anticancer therapy.
    Smolarczyk R; Cichoń T; Matuszczak S; Mitrus I; Lesiak M; Kobusińska M; Kamysz W; Jarosz M; Sieroń A; Szala S
    Arch Immunol Ther Exp (Warsz); 2012 Oct; 60(5):391-9. PubMed ID: 22922889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New immunological serum markers in bacteraemia: anti-inflammatory soluble CD163, but not proinflammatory high mobility group-box 1 protein, is related to prognosis.
    Gaïni S; Pedersen SS; Koldkaer OG; Pedersen C; Moestrup SK; Møller HJ
    Clin Exp Immunol; 2008 Mar; 151(3):423-31. PubMed ID: 18190604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High mobility group box 1 protein is released by neural cells upon different stresses and worsens ischemic neurodegeneration in vitro and in vivo.
    Faraco G; Fossati S; Bianchi ME; Patrone M; Pedrazzi M; Sparatore B; Moroni F; Chiarugi A
    J Neurochem; 2007 Oct; 103(2):590-603. PubMed ID: 17666052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The alarmin HMGB1 acts in synergy with endogenous and exogenous danger signals to promote inflammation.
    Hreggvidsdottir HS; Ostberg T; Wähämaa H; Schierbeck H; Aveberger AC; Klevenvall L; Palmblad K; Ottosson L; Andersson U; Harris HE
    J Leukoc Biol; 2009 Sep; 86(3):655-62. PubMed ID: 19564572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pivotal advance: analysis of proinflammatory activity of highly purified eukaryotic recombinant HMGB1 (amphoterin).
    Rouhiainen A; Tumova S; Valmu L; Kalkkinen N; Rauvala H
    J Leukoc Biol; 2007 Jan; 81(1):49-58. PubMed ID: 16980512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High mobility group box1 protein is involved in acute inflammation induced by Clostridium difficile toxin A.
    Liu J; Zhang BL; Sun CL; Wang J; Li S; Wang JF
    Acta Biochim Biophys Sin (Shanghai); 2016 Jun; 48(6):554-62. PubMed ID: 27151296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pivotal advance: inhibition of HMGB1 nuclear translocation as a mechanism for the anti-rheumatic effects of gold sodium thiomalate.
    Zetterström CK; Jiang W; Wähämaa H; Ostberg T; Aveberger AC; Schierbeck H; Lotze MT; Andersson U; Pisetsky DS; Erlandsson Harris H
    J Leukoc Biol; 2008 Jan; 83(1):31-8. PubMed ID: 17913975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular HMGB1 transactivates the human IL1B gene promoter through association with an Ets transcription factor PU.1.
    Mouri F; Tsukada J; Mizobe T; Higashi T; Yoshida Y; Minami Y; Izumi H; Kominato Y; Kohno K; Tanaka Y
    Eur J Haematol; 2008 Jan; 80(1):10-9. PubMed ID: 18173740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of tumor angiogenesis by HMGB1 A box peptide.
    Zhang CL; Shu MG; Qi HW; Li LW
    Med Hypotheses; 2008; 70(2):343-5. PubMed ID: 17630223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HMGB1 modulates inflammatory responses in LPS-activated macrophages.
    El Gazzar M
    Inflamm Res; 2007 Apr; 56(4):162-7. PubMed ID: 17522814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Masquerader: high mobility group box-1 and cancer.
    Ellerman JE; Brown CK; de Vera M; Zeh HJ; Billiar T; Rubartelli A; Lotze MT
    Clin Cancer Res; 2007 May; 13(10):2836-48. PubMed ID: 17504981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HMGB1 is phosphorylated by classical protein kinase C and is secreted by a calcium-dependent mechanism.
    Oh YJ; Youn JH; Ji Y; Lee SE; Lim KJ; Choi JE; Shin JS
    J Immunol; 2009 May; 182(9):5800-9. PubMed ID: 19380828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-mobility group box-1 in ischemia-reperfusion injury of the heart.
    Andrassy M; Volz HC; Igwe JC; Funke B; Eichberger SN; Kaya Z; Buss S; Autschbach F; Pleger ST; Lukic IK; Bea F; Hardt SE; Humpert PM; Bianchi ME; Mairbäurl H; Nawroth PP; Remppis A; Katus HA; Bierhaus A
    Circulation; 2008 Jun; 117(25):3216-26. PubMed ID: 18574060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.